Table 4. Effect of vWF levels on primary hemostasis in thrombocytopenic patients with cirrhosis.
25 µg r-vWF | 66 µg anti-vWF | 156 µg anti-vWF | |
Col-Epi | ↓ | ↑ | ↑ |
Col-ADP | ↔ | ↑ | ↑ |
Overview of the main results: changes in closure times after addition of either recombinant vWF or anti-vWF-antibody (↔: no change, ↓: improved, ↑: worsened).